1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,254 | 0,355 | 23.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SCANDINAVIAN CHEMOTECH Aktie jetzt für 0€ handeln | |||||
| 02.06. | Scandinavian ChemoTech AB: Scandinavian ChemoTech secures SEK 6 million Growth Loan from a larger Swedish Financial Institution | 112 | GlobeNewswire (Europe) | Scandinavian ChemoTech has secured a SEK 6 million growth loan from a larger financial institution in Sweden.
The financing forms part of ChemoTech's long-term financial strategy and will support the... ► Artikel lesen | |
| 28.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim report Q1 2026 | 231 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website January - March 2026
Net sales amounted to 2,798 KSEK (2,472)
Profit/loss after... ► Artikel lesen | |
| 07.04. | Scandinavian ChemoTech AB: ChemoTech's Proposed Strategic Changes Accepted by Nasdaq First North | 157 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB (publ) (the "Company") today announces that, based on information disclosed in the Company's press releases published on Tuesday, March 31, ahead of the notice of the Annual... ► Artikel lesen | |
| 01.04. | Scandinavian ChemoTech AB: Scandinavian ChemoTech Starts 2026 Strong with Best First Quarter in Company History | 173 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care continues its strong commercial momentum, delivering its best first quarter in the company's history in Q1 2026, with sales amounting to approx. 299,000 USD compared... ► Artikel lesen | |
| 31.03. | Scandinavian ChemoTech AB: Scandinavian ChemoTech proposes expanded business activities, name change & received proposal on directed issue | 184 | GlobeNewswire (Europe) | NOT FOR DISCLOSURE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND... ► Artikel lesen | |
| 17.02. | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Year-end report 2025 | 253 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
October - December 2025
Net sales amounted to 2,648 KSEK (2,041)
Profit/loss after... ► Artikel lesen | |
| 05.01. | Scandinavian ChemoTech AB: New Year's Letter to Shareholders in Scandinavian ChemoTech - Reflecting on 2025 | 307 | GlobeNewswire (Europe) | Dear Shareholders,
As we enter 2026, I would like to thank you for your continued trust and support of Scandinavian ChemoTech. The past year, 2025, has been an important one for the Company, a year... ► Artikel lesen | |
| 04.11.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q3 2025 | 209 | GlobeNewswire (Europe) | The report is attached to this press release and can also be downloaded from the company's website.
July - September 2025 ... ► Artikel lesen | |
| 17.10.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Surpasses 3,000 Treatments Performed Worldwide | 229 | GlobeNewswire (Europe) | Scandinavian ChemoTech's Animal Care, a pioneer in making oncology care more compassionate and human for animals, proudly announces another achievement: over 3,000 treatments have now been performed... ► Artikel lesen | |
| 01.10.25 | Scandinavian ChemoTech AB: ChemoTech's Animal Care Reports Strong Q3 Sales, Surpassing Expectations Despite Seasonal Slowdown | 249 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division is proud to announce another strong quarter, generating sales of USD 340,000 in Q3 2025. This result is within USD 50,000 of the company's record-breaking... ► Artikel lesen | |
| 26.09.25 | Scandinavian ChemoTech AB: ChemoTech's Animal Care Successfully Enters Swiss Market as Part of DACH Expansion | 596 | GlobeNewswire (Europe) | Scandinavian ChemoTech and its subsidiary VQ Animal Care Inc. is pleased to announce that it has officially started marketing vetIQure, its Tumor Specific Electroporation (TSE) technology in Switzerland.... ► Artikel lesen | |
| 10.09.25 | Scandinavian ChemoTech AB: ChemoTech Expands in Illinois as 8th Clinic within Major U.S. Veterinary Group Adopts TSE Technology | 201 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB today announced that its veterinary subsidiary, VQ Animal Care Inc., has secured a new partnership in Illinois. With this latest order, the eighth clinic within one of the... ► Artikel lesen | |
| 12.08.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech AB (publ) publishes Interim Report Q2 2025 | 259 | GlobeNewswire (Europe) | Second quarter sales reached 3,841 KSEK, which is the best quarter so far. All sales originated from Animal Care. The report is attached to this press release and can also be downloaded from the company's... ► Artikel lesen | |
| 01.07.25 | Scandinavian ChemoTech AB: Scandinavian ChemoTech's Animal Care Division Achieves Record-Breaking Sales in Q2 2025 | 275 | GlobeNewswire (Europe) | Scandinavian ChemoTech AB's Animal Care division proudly announces record-breaking sales in the second quarter of 2025. With continued momentum from a strong start to the quarter, the team achieved... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 39,900 | +0,91 % | DAX leicht unter Druck - Auto1, BMW, Fresenius, Munich Re und Vonovia im Check | Der DAX steht zum Handelsstart leicht unter Druck. Nach zwei gescheiterten Anläufen auf die 25.000-Punkte-Marke prägt Vorsicht vor dem US-Zinsentscheid am Abend das Geschehen. Gewinnmitnahmen bei US-Technologiewerten... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,550 | +0,73 % | GOLDMAN SACHS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für FMC von 38 auf 43 Euro angehoben, aber die Einstufung auf "Neutral" belassen. Analyst Richard Felton rechnet für... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 34,520 | +0,06 % | Großer Schritt geplant: Siemens Energy: Diese Abspaltung könnte zum nächsten Kursturbo werden | © Foto: Frank Rumpenhorst - dpaEin möglicher Verkauf der Industriesparte könnte bei Siemens Energy mehr Wert freisetzen, als der Kurs bisher zeigt. Analysten glauben: Das könnte erst der Anfang sein.Siemens... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 66,83 | -0,55 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BETA BIONICS | 13,670 | -0,22 % | Beta Bionics, Inc.: Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| HEARTSCIENCES | 2,750 | +55,37 % | Fortitude Mining Holdings, Inc. and HeartSciences Inc. Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets | FAIRPORT, N.Y.--(BUSINESS WIRE)--Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (Nasdaq: HSCS) ("HeartSciences")... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 26,940 | -1,75 % | DAX im Stress - Brenntag, Carl Zeiss Meditec, DWS, Infineon, RWE, Vonovia im Check | Der DAX steht zum Handelsstart unter Druck. Belastend wirken Gewinnmitnahmen in Asien und Schwäche in der Technologiebranche. Damit bleibt der Handel nahe der Rekordstände nervös, auch wenn von den... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 21,645 | +1,67 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,600 | -2,18 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 58,02 | +4,69 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| HEARTFLOW | 34,450 | +1,80 % | Heartflow, Inc. - 8-K, Current Report | ||
| GERRESHEIMER | 27,400 | +5,79 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
22.06.2026 / 11:08 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 26,610 | +1,26 % | Truist raises Progyny stock price target to $33 on growth outlook | ||
| BILLIONTOONE | 104,30 | +3,55 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| TALKSPACE | 5,200 | -0,19 % | NSE - Talkspace, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities |
SCANDINAVIAN CHEMOTECH AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,280 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCANDINAVIAN CHEMOTECH AB finden Sie auf Wallstreet Online.